| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Medical Officer
1 company
Baldo Lance is a Chief Medical Officer at ADPT. Recent filings cover 0 purchases and 25 sales. Those positions are worth an estimated $425K at current prices.
Our model assigns Baldo Lance a strong insider score of 72/100, based on 3 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +41.7%.
Baldo Lance's largest disclosed position is in ADPT as Chief Medical Officer, worth about $425K. The recent filings there lean toward selling, a net 166,473 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 6, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Medical Officer | Sale+OE | 6,250 | $40.00 | $250,000.00 | -100% | |
| Jul 6, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Medical Officer | Sale+OE | 6,250 | $47.33 | $295,788.50 | -96.9% | |
| Jun 9, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Medical Officer | Sale+OE | 6,250 | $39.67 | $247,968.17 | -76.1% | |
| May 6, 2020 | ADPT Adaptive Biotechnologies Corp | Chief Medical Officer | Sale+OE | 50,000 | $33.86 | $1,692,885.00 | -98.9% |